| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant Trastuzumab in HER2-Positive Breast Cancer: Observational Monocentric Study of 84 Cases
|
Aitelhaj, M.
|
|
|
24 |
S3 |
p. iii16
|
article
|
| 2 |
A High Frequency of Mutations is Identified in a Single Exon of the CHEK2 Gene in Greek Breast/Ovarian Patients
|
Fostira, F.
|
|
|
24 |
S3 |
p. iii13
|
article
|
| 3 |
Allelic Imbalance at the HER2/TOP2A Locus in Breast Cancer
|
Huijsmans, C.J.J.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 4 |
A Majority of Breast Cancer Specimens with 1-9 % ER Positivity Behave Like Hormone Receptor Negative Tumors
|
Desai, K.
|
|
|
24 |
S3 |
p. iii13
|
article
|
| 5 |
Androgen Receptor Expression in Breast Cancer with Special Relation to Triple-Negative Molecular Phenotype and its Response to Anterior Chemotherapy
|
Agarwal, A.A.
|
|
|
24 |
S3 |
p. iii22
|
article
|
| 6 |
An Extreme Phenotypic Expression of a Rare Brca1 Mutation in a Female Diagnosed with Early Onset Triple Negative Breast Cancer
|
Tsoukalas, N.
|
|
|
24 |
S3 |
p. iii22
|
article
|
| 7 |
An 11 Gene Q-PCR Assay to Sub-Stratify Breast Tumors Into Categories Useful in Deciding Anti-HER-2 Therapies
|
Aruna, K.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 8 |
A Novel Multigene Assay in Clinical Practice - Performance and Impact On Clinical Decisions
|
Sinn, B.V.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 9 |
Antitumor Activity of Foretinib in Breast Cancer Xenograft Mouse Models
|
Xie, M.
|
|
|
24 |
S3 |
p. iii47
|
article
|
| 10 |
Apparent Diffusion Coefficient - A Non-Invasive Biomarker for the Invasiveness of Breast Cancer
|
Bickel, H.S.
|
|
|
24 |
S3 |
p. iii40
|
article
|
| 11 |
Arachidonic Acid Induces MMP-9 Secretion in Non-Tumorigenic MCF10A Cells Through a Lipoxygenase and SRC Dependent Pathway
|
Martinez-Orozco, R.A.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 12 |
Aromatase Inhibitor and Capecitabine as 1st or 2nd Line Treatment in Metastatic Breast Cancer – A Retrospective Analysis
|
Shankar, A.
|
|
|
24 |
S3 |
p. iii19
|
article
|
| 13 |
Assessment of Genetic Alterations in Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer from the BOLERO-2 Trial by Next-Generation Sequencing
|
Piccart, M.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 14 |
Assessment of Response to Neoadjuvant Chemotherapy with Diffusion Weighted Imaging at 3T
|
Bickel, H.S.
|
|
|
24 |
S3 |
p. iii40
|
article
|
| 15 |
Association of ESR1 Polymorphisms with Tamoxifen Response in Women with Estrogen Receptor-Positive Breast Cancer
|
Almeida, M.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 16 |
AT-101 (-/- Gossypol) in Combination with Trastuzumab Triggers Apoptosis Through Inhibiting BCL-2, BCL-XL AND MCL-1 Protein Levels in Human HER2-Positive Breast Cancer Cells
|
Cakar, B.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 17 |
Author Index
|
|
|
|
24 |
S3 |
p. iii50-iii53
|
article
|
| 18 |
BAG-1 in Core Biopsies, Tissue Microarrays and Surgical Samples– Investigation of a Novel Apoptosis Biomarker in Two Independent Breast Cancer Cohorts
|
Romero, Q.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 19 |
Brain Metastases in Triple Receptor-Negative Breast Cancer: Frequency, Risk Groups and Prognosis
|
Tawfik, H.
|
|
|
24 |
S3 |
p. iii22
|
article
|
| 20 |
BRCA1 4153delA and 5382insC Mutations Confer Different Risks of Contralateral Breast and Second Primary Malignancies in Breast Cancer Patients
|
Plakhins, G.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 21 |
BRCA1 Inactivation Induces Alternative NF-κB Pathway Activation in Human Breast Cancer Cells and Mammary Glands
|
Sau, A.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 22 |
Breast Cancer Heterogeneity: the Potential Role of Maldi Imaging Mass Spectrometry in Subtyping
|
Cardinali, B.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 23 |
Breast Cancer in the Elderly - the Impact of Age On Treatment
|
Rizki, H.
|
|
|
24 |
S3 |
p. iii48
|
article
|
| 24 |
Breast Cancer in Women: Too Young or Too Old?
|
Barata, P.C.
|
|
|
24 |
S3 |
p. iii48
|
article
|
| 25 |
Changes in Gene Expression Profiles Following Pre-Surgical Statin Treatment in a Window-of-Opportunity Breast Cancer Trial
|
Bjarnadottir, O.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 26 |
Characteristics of Patients with Breast Cancer (BC) Brain Metastases (BM): Are There Any Clues for Earlier BM Diagnostic Strategies?
|
Tomasevic, Z.I.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 27 |
Chemotherapy-Induced Protracted Changes to Inflammatory Immune Potential
|
Thaxton, J.E.
|
|
|
24 |
S3 |
p. iii38
|
article
|
| 28 |
Clinical Implication of SMAD4 Expression as Prognostic Marker in Breast Cancer
|
Lee, J.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 29 |
Clinical Stage-Dependent Down-Regulation of STAT 1, 3 and 5 Expression and Induction by TH1 Cytokines in Breast Cancer Patients
|
Radenkovic, S.
|
|
|
24 |
S3 |
p. iii38
|
article
|
| 30 |
Combination of Proliferative Activity and Energy Level Changes to Predict the Malignancy and Treatment Response in Invasive Breast Cancer Patients
|
Chow, L.W.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 31 |
Comparison of Five Different Scores for the Prediction of Late Recurrence for Oestrogen Receptor-Positive Breast Cancer
|
Sestak, I.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 32 |
Comparison of the Transcriptional Response to Fulvestrant and Oestrogen Deprivation in ER-Positive Breast Cancer in Vitro and in Vivo
|
Patani, N.
|
|
|
24 |
S3 |
p. iii46
|
article
|
| 33 |
Contribution of Analytical, Pre-Analytical and Intra-Tumoral Heterogeneity to Variance in Gene Expression Measurements from Human Breast Cancers
|
Lau, R.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 34 |
CXCL13-Producing Follicular Helper CD4+ T Cells in Extensively-Infiltrated Breast Cancer Signal an Organized Immune Response and Predict Survival
|
Willard-Gallo, K.
|
|
|
24 |
S3 |
p. iii38
|
article
|
| 35 |
Deciphering Patterns of Chromosomal Aberrations in Breast Cancer Patients: How Defects in Specific DNA Repair Genes Affect the Accumulation of Gross Dna Aberrations in the Cancer Genome
|
Marquard, A.M.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 36 |
Dedicated Breast PET-CT for the Assessment of Breast Tumors: An Alternative for Patients Unsuitable for CE-MRI?
|
Magometschnigg, H.F.
|
|
|
24 |
S3 |
p. iii13
|
article
|
| 37 |
Deletions at 1P13.3 is Associated with Significantly Adverse Prognosis in Breast Cancer
|
Willis, S.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 38 |
Detection and Quantitation of Circulating Tumor Cells, Cancer Stem Cells and Endothelial Progenitor Cells Using Multiparameter Flow Cytometry
|
Sangkitporn, S.K.
|
|
|
24 |
S3 |
p. iii13
|
article
|
| 39 |
Detection of Aberrant Methylation Genes in Plasma DNA as Predictor of Therapeutic Outcome of Patients with Breast Cancer
|
Martinez-Galan, J.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 40 |
Detection of Human Papillomavirus DNA in Breast Cancer in Moroccan Woman
|
Elamrani, A.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 41 |
Diagnostic Next-Generation Sequencing Panel for Hereditary Breast and Ovarian Cancer
|
Menzel, M.M.
|
|
|
24 |
S3 |
p. iii13
|
article
|
| 42 |
Early Effect of PI3K-AKT-MTOR Blockade On in Vitro 18F-FDG Uptake in HER2+ Breast Cancer Resistant to Trastuzumab
|
Dockx, Y.
|
|
|
24 |
S3 |
p. iii40
|
article
|
| 43 |
Editorial board
|
|
|
|
24 |
S3 |
p. i-ii
|
article
|
| 44 |
Effects of mTOR Inhibition On IR/IGF-1R Signalling in PIK3CA-Mutated, Tamoxifen Resistant Breast Cancer
|
Mietzsch, F.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 45 |
Elevated Expression of ZNF703 Confers to Tamoxifen Resistance in Breast Cancer
|
Zhang, X.
|
|
|
24 |
S3 |
p. iii46
|
article
|
| 46 |
Epidemiological Characteristics of Breast Cancer in Morocco
|
Ayoujil, A.
|
|
|
24 |
S3 |
p. iii48
|
article
|
| 47 |
ER Status of Mouse Mammary Tumors in Different Microenvironments
|
Boichuk, I.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 48 |
Europa Donna
|
|
|
|
24 |
S3 |
p. iii8
|
article
|
| 49 |
Evaluation of Breast Cancer Test-Treatment Strategies Using Decision-Analytic Modeling – Preliminary Results for the 21-Gene Assay Recurrence Score
|
Jahn, B.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 50 |
Evaluation of Mammaglobin Transcription and Protein in Blood as a Marker for Diagnosis of Breast Cancer
|
Elkhouly, E.A.B.
|
|
|
24 |
S3 |
p. iii13
|
article
|
| 51 |
Evaluation of Oxygenation in Breast Cancers by Photoacoustic Mammography: Clinical and Histological Comparison
|
Fakhrejahani, E.
|
|
|
24 |
S3 |
p. iii40
|
article
|
| 52 |
Expression of Phosphorylated Proteins from PI3-Kinase and MAP-Kinase Signaling Pathways in Infiltrating Breast Cancer: Relation with Histopathologic and Molecular Subtypes
|
Merlin, J.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 53 |
Expression of SRC Kinase Family Members in Tamoxifen Treated ER Positive Breast Cancer and Association with Clinical Outcome
|
Elsberger, B.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 54 |
Expression of the 4Q12 Chromosomal Genes Kit, VEGFR2 And PDGFRα in Triple-Negative Breast Cancer
|
Aaltonen, K.E.
|
|
|
24 |
S3 |
p. iii22
|
article
|
| 55 |
Expression of XIST and 53BP1 as Predictive Markers in BRCA1 Deficient Breast Cancer
|
Schouten, P.C.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 56 |
EZH2 Promotes a Progenitor-Like Bi-Lineage Differentiation State in Basal-Like Breast Cancer Cells
|
Ben-Porath, I.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 57 |
Factors Influencing Agreement Between Core Needle Biopsy and Surgical Resection Specimens Regarding KI67 Labeling Index – Results of a Retrospective Analysis
|
Bago-Horvath, Z.
|
|
|
24 |
S3 |
p. iii13
|
article
|
| 58 |
Foundation “St.Gallen Oncology Conferences” (SONK)
|
|
|
|
24 |
S3 |
p. iii10
|
article
|
| 59 |
Frequency of Pathological Complete Response with Adriamycin and Taxanes Based Neo-Adjuvant Chemotherapy in Non-Metastatic Breast Cancer
|
Mehmood, T.
|
|
|
24 |
S3 |
p. iii18
|
article
|
| 60 |
Functional Correlation Between Phospholipase D, ERK and Paxillin in Human Breast Cancer MDA-MB-231 Cells
|
Pribic, J.
|
|
|
24 |
S3 |
p. iii46
|
article
|
| 61 |
Gain of Chromosomal Region 15Q26 Cause Increased Expression of BLM and FANCI, and is Associated with Sensitivity to Platinum Chemotherapy in Triple Negative Breast Cancer
|
Birkbak, N.J.
|
|
|
24 |
S3 |
p. iii22
|
article
|
| 62 |
GE226: A Molecular Targeted PET Imaging Agent to Assess HER2 Status in Vivo
|
Hoppmann, S.
|
|
|
24 |
S3 |
p. iii40
|
article
|
| 63 |
Genetic and Epigenetic Heterogeneity of Putative Breast Cancer Stem Cells
|
Balic, M.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 64 |
Genome-Wide Dna Copy Number Profiles Identify Lapatinib Sensitivity in Metastatic Breast Cancer Patients
|
Xie, M.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 65 |
Genomic Analysis of Drug Resistant Triple Negative Breast Cancers: A Translational Biopsy Study
|
Aguilar-Mahecha, A.
|
|
|
24 |
S3 |
p. iii22
|
article
|
| 66 |
Health Economic Analysis of Guideline and Gene Expression Signature-Based Risk Stratification of Distant Recurrence in Early Breast Cancer Patients
|
Blank, P.R.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 67 |
Heterogeneity of Genomic Signatures in Breast Cancer Core Biopsy
|
Jarzab, M.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 68 |
Identification of a Novel TNFRSF11A (RANK) Gene Variant, Produced Through Alternative Splicing and Affecting Breast Cancer Cell Survival and Migration
|
Papanastasiou, A.D.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 69 |
Identification of a Specific Gene Signature Predictive of Response to Bevacizumab in Patients with Triple-Negative Inflammatory Breast Cancer
|
Criscitiello, C.
|
|
|
24 |
S3 |
p. iii22
|
article
|
| 70 |
Identification of Brcaness in Sporadic Breast Cancers Using a Model that Integrates Multiple Assays
|
Madhumathy, G.N.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 71 |
Identification of SNPs Associated to Response of Breast Cancer Patients to Neo-Adjuvant Chemotherapy in the EORTC-10994 / BIG1-00 Randomised Phase III Trial
|
Robert, J.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 72 |
Immunohistochemical Detection of BRCA 1 Protein and PTEN Protein in Invasive Ductal Breast Cancer
|
Sarcevic, B.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 73 |
IMPAKT 2013 Officers
|
|
|
|
24 |
S3 |
p. iii11
|
article
|
| 74 |
Improving Outcomes by the Addition of Sequential Paclitaxel to Doxorubicin/Cyclophosphamide in an Adjuvant Chemotherapy Regimen for Patients with Node-Positive Primary Breast Cancer
|
Merad-Lahfa, I.
|
|
|
24 |
S3 |
p. iii16
|
article
|
| 75 |
Increased Anticancer Efficacy by the Combined Administration of Quercetin in Multidrug Resistant Breast Cancer Cells
|
Paulpandi, M.
|
|
|
24 |
S3 |
p. iii19
|
article
|
| 76 |
Infrared Imaging: a Potential New Tool to Characterize Lymphocytic Infiltration in Human Breast Cancer
|
Verdonck, M.
|
|
|
24 |
S3 |
p. iii40
|
article
|
| 77 |
Inhibition of NF- κB Regulator BCL-3 as a Novel Therapeutic Approach for HER2-Positive Breast Cancer
|
Soukupová, J.
|
|
|
24 |
S3 |
p. iii47
|
article
|
| 78 |
Interpreting Genomic Diversity for Breast Cancer: Molecular Subtypes of Breast Cancer in Very Young Women (≤35 Y) in Western Turkey
|
Karaca, B.
|
|
|
24 |
S3 |
p. iii13
|
article
|
| 79 |
Is it Possible to Tailor Breast Cancer Treatment by Using Breast Cancer Stem Cells as a Cell Model?
|
Salamoon, M.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 80 |
Lapatinib in Egyptian Women with Metastatic Breast Cancer: In Which Dose and at What Frequency?
|
Ahmed, N.
|
|
|
24 |
S3 |
p. iii19
|
article
|
| 81 |
Long-Term Effects of Early Pregnancy On the Gene Expression and Properties of Mammary Epithelial Cell Subpopulations in Mice
|
Meier-Abt, F.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 82 |
Lymphedema in Patients with Breast Cancer Undergoing Surgery and Radiotherapy
|
Singh, C.
|
|
|
24 |
S3 |
p. iii18
|
article
|
| 83 |
Metaplastic Breast Cancer: A Retrospective Analysis
|
Alexandre, M.T.
|
|
|
24 |
S3 |
p. iii19
|
article
|
| 84 |
Metastasic Breast Carcinoma to the Gallbladder and the Lower Eyelid with No Malignant Lesion in the Breast: An Unusual Case Report with a Short Review of Literature
|
Mehenni, N.N.
|
|
|
24 |
S3 |
p. iii48
|
article
|
| 85 |
Molecular Analysis of Single Circulating Tumor Cells (CTCS) Isolated from Metastatic Breast Cancer (MBC) Patients (PTS)
|
Pestrin, M.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 86 |
More Frequent Screening of the Contralateral Breast is Warranted After Treatment of Primary Node-Positive Breast Cancer
|
Abdelrhman, O.
|
|
|
24 |
S3 |
p. iii13
|
article
|
| 87 |
MRI Breast Density Assessment: An Imaging Biomarker for Identification of Women at an Increased Risk of Breast Cancer
|
Wengert, G.J.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 88 |
NCI 8609: Multicenter Phase I Trial of PARP Inhibitor Veliparib with Carboplatin in Advanced Breast Cancer
|
Ramaswamy, B.
|
|
|
24 |
S3 |
p. iii19
|
article
|
| 89 |
Neoadjuvant Chemotherapy (NAC) for Breast Cancer - Preliminary Experience from a Tertiary Cancer Center in India
|
Ghosh, I.
|
|
|
24 |
S3 |
p. iii19
|
article
|
| 90 |
Outcomes of Patients with Breast Cancer Brain Metastases: A Single Tertiary Center Experience
|
Ahluwalia, M.S.
|
|
|
24 |
S3 |
p. iii48
|
article
|
| 91 |
Plasma Proneurotensin as a Novel Biomarker for the Prediction of Incident Breast Cancer
|
Melander, O.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 92 |
Predicting Risk for Late Metastasis: the PAM50 Risk of Recurrence (ROR) Score After 5 Years of Endocrine Therapy in Postmenopausal Women with Hr+ Early Breast Cancer: a Study On 1,478 Patients from the Abcsg-8 Trial
|
Gnant, M.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 93 |
Prediction Model for Nonsentinel Lymph Node Status in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes
|
Kim, J.Y.
|
|
|
24 |
S3 |
p. iii16
|
article
|
| 94 |
Predictive Value of AKT/MTOR Pathway Immunohistochemical (IHC) Biomarkers for Response to Preoperative Trastuzumab (T) vs Trastuzumab + Everolimus (T + E) in Patients (PTS) with Early Breast Cancer (BC): Unicancer Radher Trial Results
|
Campone, M.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 95 |
Predictive Value of Bone Marrow Micrometastasis Detected by Nested RT-PCR for Cytokeratin-19 in Breast Cancer Patients
|
Kim, J.Y.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 96 |
Predictive Value of Positive Axillary Lymph Node Fine Needle Aspiration in Primary Breast Cancer
|
Yeh, Y.L.
|
|
|
24 |
S3 |
p. iii13
|
article
|
| 97 |
Preliminary Results of “Bonadiuv” Trial: A Single-Blind, Randomized, Placebo-Controlled Study Designed to Evaluate the Impact of Bisphosphonate Treatment on Bone Mineral Density in Osteopenic Women Taking Aromatase Inhibitors
|
Cecchini, S.
|
|
|
24 |
S3 |
p. iii16
|
article
|
| 98 |
Preventive Diagnostics of Breast Cancer
|
Rendic-Miocevic, Z.
|
|
|
24 |
S3 |
p. iii13
|
article
|
| 99 |
Profiling Stem Cells in Triple Negative Breast Cancer - A PCR-Array-Based Study
|
Comanescu, M.
|
|
|
24 |
S3 |
p. iii22
|
article
|
| 100 |
Prognostic and Predictive Value of IHC4 and ERB1 in the Intergroup Exemestane Study (IES) - On Behalf of the Pathies Investigators
|
Viale, G.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 101 |
Prognostic Value of a Four-Marker Panel Associated with Breast Cancer-Specific Survival
|
Parris, T.Z.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 102 |
Radiation Treatment Planning in Postmastectomy Patients - Comparison of 3D Versus 2D Plans
|
Antunac, K.
|
|
|
24 |
S3 |
p. iii18
|
article
|
| 103 |
Relation Between BMI and Morphological Characteristics Triple-Negative Breast Cancer
|
Liubota, R.
|
|
|
24 |
S3 |
p. iii22
|
article
|
| 104 |
Relationship of PIK3CA Mutation and PI3K Pathway Activity with Antiproliferative Response to Anastrozole in Er+ Breast Cancer
|
Segal, C.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 105 |
Serological Detection of Matrix Metalloproteinase Generated Fragments of Elastin and Type IV Collagen may be Biomarkers of Lung Metastatic Breast Cancer
|
Willumsen, N.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 106 |
Serum HER-2 Levels as a Predictor of Clinical Outcome in Metastatic Breast Cancer (MBC) Patients Treated with Trastuzumab-Based Therapies
|
Carney, W.P.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 107 |
Serum Thymidine Kinase Activity Compared with CA 15-3 in Locally Advanced and Metastatic Breast Cancer as Part of a Prospective and Randomized Study
|
Bjöhle, J.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 108 |
Simultaneous, Multicolour Single Molecule Imaging of the Entire Human Epidermal Growth Factor Receptor (HER) Family in Live Breast Cancer Cells
|
Zanetti-Domingues, L.C.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 109 |
SIRT1 as a Potential Therapeutic Target in Breast Cancer
|
Yen, P.H.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 110 |
Subject Index
|
|
|
|
24 |
S3 |
p. iii54-iii55
|
article
|
| 111 |
Synthesis, Characterization and in Vitro Anticancer Activity of DOX-Loaded Copper Oxide Nanoparticles Targeting Breast Cancer
|
Babu, V. Nipun
|
|
|
24 |
S3 |
p. iii19
|
article
|
| 112 |
Table of Contents
|
|
|
|
24 |
S3 |
p. iv
|
article
|
| 113 |
The Breast International Group (BIG)
|
|
|
|
24 |
S3 |
p. iii5
|
article
|
| 114 |
The Composition and Organization of Lymphocytes Infiltrating Human Breast Cancer
|
Buisseret, L.
|
|
|
24 |
S3 |
p. iii38
|
article
|
| 115 |
The European Organisation for Research and Treatment of Cancer (EORTC)
|
|
|
|
24 |
S3 |
p. iii7
|
article
|
| 116 |
The European Society for Medical Oncology (ESMO)
|
|
|
|
24 |
S3 |
p. iii6
|
article
|
| 117 |
The European Society of Breast Cancer Specialists (EUSOMA)
|
|
|
|
24 |
S3 |
p. iii9
|
article
|
| 118 |
The PIM1 Kinase Shows Genome Driven Upregulation, Suppresses Apoptosis, Enables Colony Formation and Cell Migration and is a Potential Target in Triple-Negative Breast Cancer
|
Maristany, F. Brasó
|
|
|
24 |
S3 |
p. iii22
|
article
|
| 119 |
The Possible Resolution of Tamoxifen-Induced Hot Flash by Combination with Risperidone in Breast Cancer Patients Without Interfering with the Efficacy of Tamoxifen
|
Chen, D.
|
|
|
24 |
S3 |
p. iii19
|
article
|
| 120 |
The Presence of Alveolar Structures in Breast Tumors is Associated with Drug Resistance Gene Upregulation and Poor Chemotherapy Response
|
Denisov, E.V.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 121 |
Therapeutic Targeting of Triple Negative Breast Cancer with Combinatorial Inhibition of Notch and RAS/MAPK Pathway
|
Mittal, S.
|
|
|
24 |
S3 |
p. iii22
|
article
|
| 122 |
Title page
|
|
|
|
24 |
S3 |
p. iii
|
article
|
| 123 |
Translational Research Index
|
|
|
|
24 |
S3 |
p. iii56-iii57
|
article
|
| 124 |
Trastuzumab Beyond Progression for Metastatic HER2+ Breast Cancer (MBC): Survival Outcomes in a Canadian Population
|
Rayson, D.
|
|
|
24 |
S3 |
p. iii19
|
article
|
| 125 |
Triptolide Induces Cell Death of Breast Cancer Cells via Inhibition of 14-3-3Γ Expression
|
Wang, W.
|
|
|
24 |
S3 |
p. iii43
|
article
|
| 126 |
Unravelling the Effect of Estrogen on Breast Cancer Cell Proteome Using Quantitative Proteomics
|
Pavlou, M.P.
|
|
|
24 |
S3 |
p. iii25
|
article
|
| 127 |
Upregulation of IL15RA in Triple Negative Breast Cancer (TNBC) Promotes Tumour Cell Growth and Motility and Can Activate an Immune Cell Response
|
Marra, P.
|
|
|
24 |
S3 |
p. iii38
|
article
|
| 128 |
Use of Live In-Vivo Lymphatic Imaging Techniques to Study the Effects of Immune Cell Interactions in a Syngeneic Mouse Model of Breast Cancer
|
Irshad, S.
|
|
|
24 |
S3 |
p. iii40
|
article
|
| 129 |
Use of Markers of Bone Turnover (CTX and P1NP) for Monitoring the Response to Therapy Bone Metastases Breast Cancer
|
Brancikova, D.
|
|
|
24 |
S3 |
p. iii29
|
article
|
| 130 |
Using Fourier-Transformed Infrared (FTIR) Spectroscopic Imaging and Principal Component Analysis - Fuzzy C-Means (PCA-FCM) for Improvement on Breast Cancer Prognosis
|
Idris, A.F.
|
|
|
24 |
S3 |
p. iii40
|
article
|
| 131 |
Validation of BRCA Mutation-Carrier Probability Model, BRCAPRO in the Japanese Population
|
Ito, M.
|
|
|
24 |
S3 |
p. iii13
|
article
|
Journal description